Welcome to Episode #177 of the Zacks Market Edge Podcast.

Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.

In this episode, Tracey is joined by Zacks Chief Equity Strategist, John Blank, to discuss the escalation of the trade tensions between the United States and China.

Now that the United States has instituted the 25% tariffs, and China has retaliated with tariffs of their own, what are the implications for the global economy for the rest of this year?

Is a recession looming?

John’s answer might surprise you.

Wall Street: “Sell Now, Buy Back in Later”

For stock investors, however, it’s a tough environment.

Wall Street hates uncertainty. For now, Wall Street is selling and going to the sidelines. But at some point, the sentiment will change.

Investors will want to get back in.

Where do you hide out in the meantime?

Strategies for Stock Investing During a Trade War

There’s something to be said for having your business banned in China: you’re not impacted by trade tensions.

American social media and Internet stocks, with no direct business in China, might be a place to hide out. Those would be names like Facebook , Twitter and Alphabet (GOOGL - Free Report) .  

Additionally, investors could go the opposite route and buy Chinese stocks with no direct business in the United States, like Chinese Internet giant Baidu (BIDU - Free Report) .

But what about the big international stocks like Alibaba (BABA - Free Report) ? There’s a lot of uncertainty as to what a trade war might do to its business if the Chinese economy slows.

What other industries should you be buying, or avoiding, over the next few months?

Find out on this week’s podcast.

[In full disclosure, the author of this article owns shares of FB and GOOGL in her personal portfolio.]

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>